Cannabinoid company Cronos Group, Inc. (CRON,CRON.TO) announced Wednesday the appointment of Anna Shlimak as Chief Financial Officer, effective today. Shlimak will succeed James Holm, who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition.
Shlimak has been an integral part of Cronos' leadership team for the last seven years, playing a key role in shaping the Company's strategy, operational efficiencies, and engagement with the financial and investment community.
During her tenure, she has led many strategic initiatives including cost optimization, revenue growth, and building Cronos' corporate brand, which have positioned the Company for long-term success.
Shlimak recently served as the Company's Chief Strategy Officer and was responsible for managing and directing the organization's corporate strategy, investor relations, communications, government affairs, and information systems departments.
Prior to joining Cronos, Shlimak was the Head of Investor Relations at Quest Partners LLC, a research-driven alternative investment firm. Before that, Shlimak held a range of roles at the New York Stock Exchange in both the New York and London offices.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.